StonvexLoading…
StonvexStonvexStonvexCore line items from AMRZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $11.81B | $11.70B | $11.68B |
Operating Income | $1.91B | $2.19B | $1.89B |
Net Income | $1.19B | $1.27B | $956.00M |
EPS (Diluted) | $2.14 | $2.30 | $1.73 |
Total Assets | $24.25B | $23.80B | Not available |
Total Liabilities | $10.99B | $13.89B | Not available |
Cash & Equivalents | $1.92B | $1.58B | $1.11B |
Free Cash Flow OCF − CapEx | $1.42B | $1.64B | $1.41B |
Shares Outstanding | 553.08M | 553.10M | 553.10M |